Axsome Therapeutics, Inc.

( )
AXSM PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
HZNPHorizon Therapeutics Plc -1.35%61.196.5%$119.67m
VRXValeant Pharmaceuticals International, Inc. -3.13%18.2614.1%$107.44m
CTLTCatalent, Inc. -0.85%87.352.1%$92.52m
TNXPTonix Pharmaceuticals Holding Corp. -2.33%1.260.5%$64.76m
BHCBausch Health Cos., Inc. -3.13%18.260.0%$62.50m
JAZZJazz Pharmaceuticals Plc -4.85%108.252.4%$56.70m
ARGXargenx SE 1.03%232.510.0%$46.45m
UTHRUnited Therapeutics Corp. -1.79%111.4714.3%$44.65m
ICLRICON plc 0.13%185.464.3%$42.66m
ICPTIntercept Pharmaceuticals, Inc. -2.27%45.6416.8%$40.69m
PCRXPacira Biosciences, Inc. -0.96%52.6110.3%$39.36m
PRGOPerrigo Co. Plc -0.19%52.926.8%$38.62m
GWPHGW Pharmaceuticals Plc 3.97%132.706.2%$36.96m
VRNAVerona Pharma Plc -4.48%6.820.0%$33.05m
MYOKMyoKardia, Inc. -0.03%90.101.8%$32.59m

Company Profile

Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its product candidates include AXS-05, AXS-07, AXS-09, AXS-12, and AXS-14 which are developing for multiple pain and primary care indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.